melomo personal page - To The Moon

melomo

No personal profile

7Follow

0Followers

0Topic

0Badge

2021-06-28

lets get rich

3 Low-Risk Stocks for Conservative Investors

2021-06-15

?

Lordstown shares tumbled nearly 20% in moring trading

2021-06-15

good

DoorDash Announces Partnership with PetSmart® Offering On-Demand Delivery of Pet Essentials

2021-06-15

??

Lilly to Participate in Guggenheim Biopharma Strategy Series

2021-06-15

hao

Vaccine Stocks Slide After Novavax Shot Proves Highly Effective

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3581938241439452,"uuid":"3581938241439452","gmtCreate":1618844662880,"gmtModify":1618844662880,"name":"melomo","pinyin":"melomo","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":7,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":150341784,"gmtCreate":1624888407948,"gmtModify":1703847113016,"author":{"id":"3581938241439452","authorId":"3581938241439452","authorIdStr":"3581938241439452","name":"melomo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581938241439452"},"themes":[],"htmlText":"lets get rich","listText":"lets get rich","text":"lets get rich","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/150341784","repostId":"2146835749","repostType":4,"repost":{"id":"2146835749","pubTimestamp":1624888031,"share":"https://ttm.financial/m/news/2146835749?lang=&edition=fundamental","pubTime":"2021-06-28 21:47","market":"us","language":"en","title":"3 Low-Risk Stocks for Conservative Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2146835749","media":"Motley Fool","summary":"These all-weather stocks can still help you build a market-beating portfolio.","content":"<p>The level of risk you're willing to maintain in your portfolio at any given time very much depends on your personal comfort level and investment goals. And the truth is, you don't need to hold a basket of high-risk/high-reward stocks to generate notable and consistent portfolio returns.</p>\n<p>If you want to maximize your portfolio growth without exposing yourself to excessive risk, there are plenty of high-quality stocks to pick from that can help you do just that. Let's take a look at three such safe stocks for long-term investors to buy right now.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4425f21b4312d33cf18d53a2231e7b89\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>When it comes to tried-and-true companies with a robust selection of products and a track record of resilience in a variety of economic conditions, <a href=\"https://laohu8.com/S/AONE\">one</a> of the top healthcare stocks that comes to mind is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). After nearly a century and a half in business, the company has pulled through many storms in its time, and the volatility of the pandemic market was no different.</p>\n<p>While Johnson &amp; Johnson reported mixed quarterly results in 2020, it still finished the full year with 0.6% total sales growth for the 12-month period. While that may seem like a modest increase, it's actually the same rate of sales growth the company reported in 2019 before the pandemic hit. Johnson &amp; Johnson's total sales growth in 2020 was bolstered by 3% sales growth in its consumer health segment and an 8% bump in pharmaceutical segment sales.</p>\n<p>In Johnson &amp; Johnson's most recent quarterly report for the first quarter of 2021, it was clear that the company's balance sheet was rebounding from any lag it may have experienced as a result of the pandemic. During the three-month period, the company's total sales increased 7.9% on a year-over-year basis, and its net earnings grew 7% year over year.</p>\n<p>In fact, Johnson &amp; Johnson's strong performance during the quarter led management to boost the company's full-year guidance. The company is targeting more than 9% adjusted operational sales growth and an increase in adjusted operational earnings per share (EPS) of approximately 17% for 2021.</p>\n<p>Johnson &amp; Johnson had several catalysts in its portfolio to thank for its robust top- and bottom-line growth in the first quarter, including single-digit sales increases in both its pharmaceutical and medical device segments. While overall sales in Johnson &amp; Johnson's consumer health segment fell slightly in the quarter, sales of its skin health/beauty, oral care, and baby care products still surged by respective rates of 4%, 6%, and 8% year over year.</p>\n<p>The company also recorded notable sales growth for a number of its top-selling pharmaceutical products. For example, first-quarter sales of its immunology drugs Stelara and Tremfya increased by respective amounts of 18% and 41% from the year-ago period. And sales of its oncology drugs Darzalex, Erleada, and Imbruvica popped 46%, 83%, and 9% year over year.</p>\n<p>Meanwhile, shares of Johnson &amp; Johnson have grown by more than 17% over the past year and about 5% year to date. Johnson &amp; Johnson is also a Dividend King that yields about 2.6% right now. And with nearly six decades of consecutive dividend boosts behind it, shareholders can be confident in the company's commitment to its payout. Long-term investors searching for an all-weather stock to buy can find safe harbor in Johnson &amp; Johnson's stable growth trajectory, steady share price increases, and robust dividend.</p>\n<h2>2. Costco Wholesale</h2>\n<p>If you're searching for another stable stock to add to your buy basket, <b>Costco Wholesale</b> (NASDAQ:COST) is a smart choice to add to your list. The company owns and operates hundreds of warehouses around the world, with its most robust presence in North America. Costco also has a burgeoning e-commerce presence that has gone from strength to strength since the beginning of the pandemic.</p>\n<p>Costco reports its fiscal year a bit differently than some other companies. Its fiscal 2020 concluded on Aug. 30, 2020. During the 12-month period, the company's net sales grew by more than 9%, while its comparable sales increased by about 8%. However, e-commerce comparable sales jumped by an eye-popping 50% compared to fiscal 2019.</p>\n<p>In the first three quarters of Costco's fiscal 2021 (ended Nov. 22, Feb. 14, and May 9), it reported net sales increases of 17%, 15%, and 22% from the year-ago periods. The company's comparable sales for these quarters also marked double-digit increases of 15%, 13%, and 21% on a year-over-year basis.</p>\n<p>Once again, Costco recorded the largest rates of year-over-year growth from e-commerce sales. During the first three quarters of the company's fiscal 2021, its e-commerce comp sales spiked by respective percentages of 86%, 76%, and 41% from the same quarters in fiscal 2020.</p>\n<p>Costco owes its stellar financial performance in varied market conditions to the constant demand for its products and services, which also makes it an appealing buy for long-term investors. The company was <a href=\"https://laohu8.com/S/AONE.U\">one</a> of a number of big-box retailers that maintained \"essential business\" status during the lockdown days of the pandemic. From daily essentials, to clothing, to electronics, to household appliances, to pharmacy services, members can find just about anything they need at Costco's warehouses.</p>\n<p>As Costco's business and balance sheet have continued to expand during the pandemic, so has its share price. The stock is currently trading more than 30% higher than one year ago and is up 4% from the beginning of this year.</p>\n<p>On a final note, Costco also pays a dividend that yields just a little under 1% at the time of this writing, and which it regularly increases. If you're looking for dividend income, consistent portfolio growth, and recession resilience, this high-caliber consumer staples stock offers investors the best of all worlds.</p>\n<h2>3. Procter &amp; Gamble</h2>\n<p>The final pick on today's list is another premium buy in the world of consumer staples. <b>Procter &amp; Gamble </b>(NYSE:PG) has been in business for nearly two centuries, and its comprehensive portfolio of products continues to drive meaningful growth regardless of market headwinds or periods of economic downturn.</p>\n<p>The company pays a healthy dividend that yields about 2.6% based on current share prices. Like Johnson &amp; Johnson, Procter &amp; Gamble is a Dividend King, but with an even lengthier track record of dividend increases. The company has consistently increased its dividend payout for 64 years in a row.</p>\n<p>Procter &amp; Gamble's products are used daily in households around the world, and it has a brand authority few companies can compete with. Among its family of brands are well-known names like Vicks, Pepto-Bismol, Ivory, Olay, Old Spice, Febreze, Gillette, Bounty, Charmin, and Tide. The durable demand for Procter &amp; Gamble's products and its established history of growth makes the company an appealing stock buy in any market environment.</p>\n<p>In the first three quarters of the company's fiscal 2021 (ended Sep. 30, Dec. 31, and March 31), Procter &amp; Gamble said that its net sales grew by respective rates of 9%, 8%, and 5% from the year-ago periods. The company also consistently increased its net earnings on a year-over-year basis during these three quarters: 19% in the first, 4% in the second, and 12% in the third.</p>\n<p>The company closed the most recent quarter with $10 billion in cash and cash equivalents out of about $117 billion in total assets. It also reported that it had approximately $8.8 billion in debt due within the next year, giving it plenty of liquidity to pay down its liabilities and continue covering its shareholder obligations. And Procter &amp; Gamble generated $4.1 billion in operating cash flow in the third quarter of its fiscal 2021 alone.</p>\n<p>Shares of Procter &amp; Gamble have retracted slightly from the beginning of the year but are still trading about 17% higher than this time last year.</p>\n<p>With its juicy dividend yield and strong balance sheet performance both through the decades and amid the tumultuous market conditions of the past year plus, Procter &amp; Gamble is a golden egg to add to your portfolio that can generate consistent growth for the long haul.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Low-Risk Stocks for Conservative Investors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Low-Risk Stocks for Conservative Investors\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-28 21:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/28/3-low-risk-stocks-for-conservative-investors/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The level of risk you're willing to maintain in your portfolio at any given time very much depends on your personal comfort level and investment goals. And the truth is, you don't need to hold a ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/28/3-low-risk-stocks-for-conservative-investors/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COST":"好市多","JNJ":"强生","PG":"宝洁","ISBC":"投资者银行"},"source_url":"https://www.fool.com/investing/2021/06/28/3-low-risk-stocks-for-conservative-investors/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146835749","content_text":"The level of risk you're willing to maintain in your portfolio at any given time very much depends on your personal comfort level and investment goals. And the truth is, you don't need to hold a basket of high-risk/high-reward stocks to generate notable and consistent portfolio returns.\nIf you want to maximize your portfolio growth without exposing yourself to excessive risk, there are plenty of high-quality stocks to pick from that can help you do just that. Let's take a look at three such safe stocks for long-term investors to buy right now.\nImage source: Getty Images.\n1. Johnson & Johnson\nWhen it comes to tried-and-true companies with a robust selection of products and a track record of resilience in a variety of economic conditions, one of the top healthcare stocks that comes to mind is Johnson & Johnson (NYSE:JNJ). After nearly a century and a half in business, the company has pulled through many storms in its time, and the volatility of the pandemic market was no different.\nWhile Johnson & Johnson reported mixed quarterly results in 2020, it still finished the full year with 0.6% total sales growth for the 12-month period. While that may seem like a modest increase, it's actually the same rate of sales growth the company reported in 2019 before the pandemic hit. Johnson & Johnson's total sales growth in 2020 was bolstered by 3% sales growth in its consumer health segment and an 8% bump in pharmaceutical segment sales.\nIn Johnson & Johnson's most recent quarterly report for the first quarter of 2021, it was clear that the company's balance sheet was rebounding from any lag it may have experienced as a result of the pandemic. During the three-month period, the company's total sales increased 7.9% on a year-over-year basis, and its net earnings grew 7% year over year.\nIn fact, Johnson & Johnson's strong performance during the quarter led management to boost the company's full-year guidance. The company is targeting more than 9% adjusted operational sales growth and an increase in adjusted operational earnings per share (EPS) of approximately 17% for 2021.\nJohnson & Johnson had several catalysts in its portfolio to thank for its robust top- and bottom-line growth in the first quarter, including single-digit sales increases in both its pharmaceutical and medical device segments. While overall sales in Johnson & Johnson's consumer health segment fell slightly in the quarter, sales of its skin health/beauty, oral care, and baby care products still surged by respective rates of 4%, 6%, and 8% year over year.\nThe company also recorded notable sales growth for a number of its top-selling pharmaceutical products. For example, first-quarter sales of its immunology drugs Stelara and Tremfya increased by respective amounts of 18% and 41% from the year-ago period. And sales of its oncology drugs Darzalex, Erleada, and Imbruvica popped 46%, 83%, and 9% year over year.\nMeanwhile, shares of Johnson & Johnson have grown by more than 17% over the past year and about 5% year to date. Johnson & Johnson is also a Dividend King that yields about 2.6% right now. And with nearly six decades of consecutive dividend boosts behind it, shareholders can be confident in the company's commitment to its payout. Long-term investors searching for an all-weather stock to buy can find safe harbor in Johnson & Johnson's stable growth trajectory, steady share price increases, and robust dividend.\n2. Costco Wholesale\nIf you're searching for another stable stock to add to your buy basket, Costco Wholesale (NASDAQ:COST) is a smart choice to add to your list. The company owns and operates hundreds of warehouses around the world, with its most robust presence in North America. Costco also has a burgeoning e-commerce presence that has gone from strength to strength since the beginning of the pandemic.\nCostco reports its fiscal year a bit differently than some other companies. Its fiscal 2020 concluded on Aug. 30, 2020. During the 12-month period, the company's net sales grew by more than 9%, while its comparable sales increased by about 8%. However, e-commerce comparable sales jumped by an eye-popping 50% compared to fiscal 2019.\nIn the first three quarters of Costco's fiscal 2021 (ended Nov. 22, Feb. 14, and May 9), it reported net sales increases of 17%, 15%, and 22% from the year-ago periods. The company's comparable sales for these quarters also marked double-digit increases of 15%, 13%, and 21% on a year-over-year basis.\nOnce again, Costco recorded the largest rates of year-over-year growth from e-commerce sales. During the first three quarters of the company's fiscal 2021, its e-commerce comp sales spiked by respective percentages of 86%, 76%, and 41% from the same quarters in fiscal 2020.\nCostco owes its stellar financial performance in varied market conditions to the constant demand for its products and services, which also makes it an appealing buy for long-term investors. The company was one of a number of big-box retailers that maintained \"essential business\" status during the lockdown days of the pandemic. From daily essentials, to clothing, to electronics, to household appliances, to pharmacy services, members can find just about anything they need at Costco's warehouses.\nAs Costco's business and balance sheet have continued to expand during the pandemic, so has its share price. The stock is currently trading more than 30% higher than one year ago and is up 4% from the beginning of this year.\nOn a final note, Costco also pays a dividend that yields just a little under 1% at the time of this writing, and which it regularly increases. If you're looking for dividend income, consistent portfolio growth, and recession resilience, this high-caliber consumer staples stock offers investors the best of all worlds.\n3. Procter & Gamble\nThe final pick on today's list is another premium buy in the world of consumer staples. Procter & Gamble (NYSE:PG) has been in business for nearly two centuries, and its comprehensive portfolio of products continues to drive meaningful growth regardless of market headwinds or periods of economic downturn.\nThe company pays a healthy dividend that yields about 2.6% based on current share prices. Like Johnson & Johnson, Procter & Gamble is a Dividend King, but with an even lengthier track record of dividend increases. The company has consistently increased its dividend payout for 64 years in a row.\nProcter & Gamble's products are used daily in households around the world, and it has a brand authority few companies can compete with. Among its family of brands are well-known names like Vicks, Pepto-Bismol, Ivory, Olay, Old Spice, Febreze, Gillette, Bounty, Charmin, and Tide. The durable demand for Procter & Gamble's products and its established history of growth makes the company an appealing stock buy in any market environment.\nIn the first three quarters of the company's fiscal 2021 (ended Sep. 30, Dec. 31, and March 31), Procter & Gamble said that its net sales grew by respective rates of 9%, 8%, and 5% from the year-ago periods. The company also consistently increased its net earnings on a year-over-year basis during these three quarters: 19% in the first, 4% in the second, and 12% in the third.\nThe company closed the most recent quarter with $10 billion in cash and cash equivalents out of about $117 billion in total assets. It also reported that it had approximately $8.8 billion in debt due within the next year, giving it plenty of liquidity to pay down its liabilities and continue covering its shareholder obligations. And Procter & Gamble generated $4.1 billion in operating cash flow in the third quarter of its fiscal 2021 alone.\nShares of Procter & Gamble have retracted slightly from the beginning of the year but are still trading about 17% higher than this time last year.\nWith its juicy dividend yield and strong balance sheet performance both through the decades and amid the tumultuous market conditions of the past year plus, Procter & Gamble is a golden egg to add to your portfolio that can generate consistent growth for the long haul.","news_type":1},"isVote":1,"tweetType":1,"viewCount":73,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184891173,"gmtCreate":1623697244792,"gmtModify":1704208943656,"author":{"id":"3581938241439452","authorId":"3581938241439452","authorIdStr":"3581938241439452","name":"melomo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581938241439452"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184891173","repostId":"1135770375","repostType":4,"repost":{"id":"1135770375","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623678372,"share":"https://ttm.financial/m/news/1135770375?lang=&edition=fundamental","pubTime":"2021-06-14 21:46","market":"us","language":"en","title":"Lordstown shares tumbled nearly 20% in moring trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1135770375","media":"Tiger Newspress","summary":"Lordstown shares tumbled nearly 20% in moring trading.\n\nElectric-vehicle maker Lordstown Motors Corp","content":"<p>Lordstown&nbsp;shares&nbsp;tumbled&nbsp;nearly&nbsp;20%&nbsp;in&nbsp;moring&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/71ab214ec35da9043a3ec41746785e3f\" tg-width=\"800\" tg-height=\"625\" referrerpolicy=\"no-referrer\"></p>\n<p>Electric-vehicle maker <a href=\"https://laohu8.com/S/RIDE\">Lordstown Motors Corp.</a> announced the abrupt departure of its two top executives as it attempts to transition from research and development into commercial production of its first model.</p>\n<p>The startup said in a statement Monday that Chief Executive Officer Steve Burns and Chief Financial Officer Julio Rodriguez have resigned from the company, effective immediately.</p>\n<p>It is the latest setback for the company, which warned last week it might not have enough cash to fund development of its first truck or even survive the next 12 months if it can’t raise more capital. In March, the startup disclosed a Securities and Exchange Commission probe of its operations after a short seller said its technology was flawed and that pre-orders for its truck were nonbinding.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lordstown shares tumbled nearly 20% in moring trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLordstown shares tumbled nearly 20% in moring trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-14 21:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Lordstown&nbsp;shares&nbsp;tumbled&nbsp;nearly&nbsp;20%&nbsp;in&nbsp;moring&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/71ab214ec35da9043a3ec41746785e3f\" tg-width=\"800\" tg-height=\"625\" referrerpolicy=\"no-referrer\"></p>\n<p>Electric-vehicle maker <a href=\"https://laohu8.com/S/RIDE\">Lordstown Motors Corp.</a> announced the abrupt departure of its two top executives as it attempts to transition from research and development into commercial production of its first model.</p>\n<p>The startup said in a statement Monday that Chief Executive Officer Steve Burns and Chief Financial Officer Julio Rodriguez have resigned from the company, effective immediately.</p>\n<p>It is the latest setback for the company, which warned last week it might not have enough cash to fund development of its first truck or even survive the next 12 months if it can’t raise more capital. In March, the startup disclosed a Securities and Exchange Commission probe of its operations after a short seller said its technology was flawed and that pre-orders for its truck were nonbinding.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135770375","content_text":"Lordstown shares tumbled nearly 20% in moring trading.\n\nElectric-vehicle maker Lordstown Motors Corp. announced the abrupt departure of its two top executives as it attempts to transition from research and development into commercial production of its first model.\nThe startup said in a statement Monday that Chief Executive Officer Steve Burns and Chief Financial Officer Julio Rodriguez have resigned from the company, effective immediately.\nIt is the latest setback for the company, which warned last week it might not have enough cash to fund development of its first truck or even survive the next 12 months if it can’t raise more capital. In March, the startup disclosed a Securities and Exchange Commission probe of its operations after a short seller said its technology was flawed and that pre-orders for its truck were nonbinding.","news_type":1},"isVote":1,"tweetType":1,"viewCount":240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184893029,"gmtCreate":1623697122361,"gmtModify":1704208941714,"author":{"id":"3581938241439452","authorId":"3581938241439452","authorIdStr":"3581938241439452","name":"melomo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581938241439452"},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/184893029","repostId":"2143787080","repostType":4,"repost":{"id":"2143787080","pubTimestamp":1623678240,"share":"https://ttm.financial/m/news/2143787080?lang=&edition=fundamental","pubTime":"2021-06-14 21:44","market":"us","language":"en","title":"DoorDash Announces Partnership with PetSmart® Offering On-Demand Delivery of Pet Essentials","url":"https://stock-news.laohu8.com/highlight/detail?id=2143787080","media":"PR Newswire","summary":"Customers nationwide can now access same-day delivery of pet supplies through DoorDash\nSAN FRANCISCO","content":"<div>\n<p>Customers nationwide can now access same-day delivery of pet supplies through DoorDash\nSAN FRANCISCO, June 14, 2021 /PRNewswire/ -- DoorDash (NYSE: DASH), the nation's leading last-mile logistics ...</p>\n\n<a href=\"https://finance.yahoo.com/news/doordash-announces-partnership-petsmart-offering-130000428.html\">Web Link</a>\n\n</div>\n","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DoorDash Announces Partnership with PetSmart® Offering On-Demand Delivery of Pet Essentials</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDoorDash Announces Partnership with PetSmart® Offering On-Demand Delivery of Pet Essentials\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 21:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/doordash-announces-partnership-petsmart-offering-130000428.html><strong>PR Newswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Customers nationwide can now access same-day delivery of pet supplies through DoorDash\nSAN FRANCISCO, June 14, 2021 /PRNewswire/ -- DoorDash (NYSE: DASH), the nation's leading last-mile logistics ...</p>\n\n<a href=\"https://finance.yahoo.com/news/doordash-announces-partnership-petsmart-offering-130000428.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DASH":"DoorDash, Inc."},"source_url":"https://finance.yahoo.com/news/doordash-announces-partnership-petsmart-offering-130000428.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2143787080","content_text":"Customers nationwide can now access same-day delivery of pet supplies through DoorDash\nSAN FRANCISCO, June 14, 2021 /PRNewswire/ -- DoorDash (NYSE: DASH), the nation's leading last-mile logistics platform, announced today a partnership with leading pet specialty retailer PetSmart to facilitate on-demand delivery of pet supplies and accessories across nearly 1,500 PetSmart locations nationwide. Customers can now order pet products for on-demand delivery through the DoorDash app or website in addition to the Petsmart.com website for same-day delivery powered exclusively through DoorDash Drive, DoorDash's white-label fulfillment platform that powers direct delivery for any business.\n\nDoorDash will offer more than 11,000 items from PetSmart including pet food, toys and treats, habitats and supplements, and more. Pet parents can now shop for everything they need for the lifetime care of their pets in a convenient and accessible way through the DoorDash app.\n\"As we continue to accelerate our entry into new categories to meet consumers' adapting on-demand needs, we are thrilled by the opportunity to continue to work with PetSmart to provide pet owners with all the animal essentials they need conveniently and reliably right on the DoorDash app,\" said Christopher Payne, President at DoorDash.\n\"At PetSmart we understand our customers' needs are always evolving,\" said Will Smith, Senior Vice President and Chief Marketing Officer at PetSmart. \"We're delighted to partner with DoorDash to provide pet parents with access to the essentials they need, right when they need them.\"\nDoorDash partner and NASCAR driver Bubba Wallace and his dog Asher star in the new DoorDash multi-platform marketing campaign to celebrate the launch of the partnership with PetSmart. \"Asher the Dasher\"–a high-energy TV, digital, social, campaign–will launch with a :30 TV spot  featuring Bubba Wallace and Asher airing today with additional video content running across social and digital.\n\"As a new pet parent, I am so excited to see DoorDash partner with PetSmart to make same-day delivery of pet supplies a reality,\" said Bubba Wallace. \"Whether Asher is with me on the road or at home, the fact that I can now order him all his favorite treats and essentials and get them delivered on-demand is a gamechanger.\"\nPetSmart is available on DashPass, DoorDash's membership program that offers members unlimited $0 delivery fees and reduced service fees from thousands of restaurants, grocery, and convenience stores nationwide. DashPass members can enjoy these benefits on all eligible orders from PetSmart.\n\"Asher the Dasher\" was created in partnership with Bokeh, a SF-based creative agency tasked with bringing the campaign to life. The campaign was directed by Paul Trillo and produced by Greg Speck with Monica Lo as Creative Director.\nAbout DoorDash\nDoorDash is a technology company that connects consumers with their favorite local and national businesses in more than 4,000 cities and all 50 states across the United States, Canada, and Australia. Founded in 2013, DoorDash enables local businesses to address consumers' expectations of ease and immediacy and thrive in today's convenience economy. By building the last-mile logistics infrastructure for local commerce, DoorDash is bringing communities closer, one doorstep at a time.\nAbout PetSmart\nPetSmart LLC is the largest specialty pet retailer of services and solutions for the lifetime needs of pets. At PetSmart, we love pets, and we believe pets make us better people. Every day with every connection, PetSmart's passionate associates help bring pet parents closer to their pets so they, together, can live more fulfilled lives. This vision impacts everything we do for our customers, the way we support our associates and how we give back to our communities.\nPetSmart operates approximately 1,650 pet stores in the United States, Canada and Puerto Rico, as well as more than 200 in-store PetSmart PetsHotel® dog and cat boarding facilities. The retailer provides a broad range of competitively priced pet food and products, as well as services such as dog training, pet grooming, pet boarding, PetSmart Doggie Day Camp™ and pet adoption.\nPetSmart, PetSmart Charities® and PetSmart Charities® of Canada work with nearly 4,000 animal welfare organizations to bring adoptable pets into stores so they have the best chance possible of finding a forever home. Through this in-store adoption program and other signature events, PetSmart has facilitated more than 9 million adoptions, more than any other brick-and-mortar organization.","news_type":1},"isVote":1,"tweetType":1,"viewCount":482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184899746,"gmtCreate":1623697108385,"gmtModify":1704208941391,"author":{"id":"3581938241439452","authorId":"3581938241439452","authorIdStr":"3581938241439452","name":"melomo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581938241439452"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184899746","repostId":"2143780690","repostType":4,"repost":{"id":"2143780690","pubTimestamp":1623680040,"share":"https://ttm.financial/m/news/2143780690?lang=&edition=fundamental","pubTime":"2021-06-14 22:14","market":"us","language":"en","title":"Lilly to Participate in Guggenheim Biopharma Strategy Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2143780690","media":"PR Newswire","summary":"INDIANAPOLIS, June 14, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in th","content":"<div>\n<p>INDIANAPOLIS, June 14, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Biopharma Strategy Series – Biopharma's Next Decade: Views from the Top on Global ...</p>\n\n<a href=\"https://finance.yahoo.com/news/lilly-participate-guggenheim-biopharma-strategy-140000747.html\">Web Link</a>\n\n</div>\n","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lilly to Participate in Guggenheim Biopharma Strategy Series</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLilly to Participate in Guggenheim Biopharma Strategy Series\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 22:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/lilly-participate-guggenheim-biopharma-strategy-140000747.html><strong>PR Newswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>INDIANAPOLIS, June 14, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Biopharma Strategy Series – Biopharma's Next Decade: Views from the Top on Global ...</p>\n\n<a href=\"https://finance.yahoo.com/news/lilly-participate-guggenheim-biopharma-strategy-140000747.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://finance.yahoo.com/news/lilly-participate-guggenheim-biopharma-strategy-140000747.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2143780690","content_text":"INDIANAPOLIS, June 14, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Biopharma Strategy Series – Biopharma's Next Decade: Views from the Top on Global Strategy and Innovation – on Friday, June 18, 2021. Daniel Skovronsky, M.D., Ph.D., Lilly's Chief Scientific and Medical Officer and President of Lilly Research Laboratories, will participate in a virtual fireside chat at 11:00 a.m., Eastern Time.\nA live audio webcast will be available on the \"Webcasts & Presentations\" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.\nAbout Eli Lilly and Company \nLilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/news. F-LLY","news_type":1},"isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184899289,"gmtCreate":1623697094241,"gmtModify":1704208941230,"author":{"id":"3581938241439452","authorId":"3581938241439452","authorIdStr":"3581938241439452","name":"melomo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581938241439452"},"themes":[],"htmlText":"hao","listText":"hao","text":"hao","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184899289","repostId":"2143738859","repostType":4,"repost":{"id":"2143738859","pubTimestamp":1623684317,"share":"https://ttm.financial/m/news/2143738859?lang=&edition=fundamental","pubTime":"2021-06-14 23:25","market":"us","language":"en","title":"Vaccine Stocks Slide After Novavax Shot Proves Highly Effective","url":"https://stock-news.laohu8.com/highlight/detail?id=2143738859","media":"Bloomberg","summary":"(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’","content":"<p>(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’s shots showed they were 90% effective at preventing symptoms.</p>\n<p>Stocks tied to inoculations already cleared for emergency use fell in Monday’s trading, led by Moderna Inc.’s slide of as much as 9.5%. Pfizer Inc. fell 1.6% and the drugmaker’s German partner <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> dropped 6.1%. Even the consumer giant Johnson &amp; Johnson slipped 0.6%, slightly more than the S&amp;P 500 index as the broader market dropped back from Friday’s record highs.</p>\n<p>Novavax itself wasn’t immune from the downdraft it created, with the stock reversing a 9.5% gain on Monday to fall about 1%. The shot’s efficacy was better than Wall Street was expecting amid the spread of more resistant variants, and that’s raising the specter of new competition. Novavax now has “a viable alternative to mRNA vaccines,” like Pfizer and BioNTech or Moderna’s shots, an analyst at Jefferies said.</p>\n<p>But with Novavax up 91% so far this year and after a more than 2,700% leap in 2020, it wasn’t enough to further bolster shares. Biotech stocks often climb ahead of highly watched catalyst, only to give back gains even after a positive update.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks Slide After Novavax Shot Proves Highly Effective</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks Slide After Novavax Shot Proves Highly Effective\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 23:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/vaccine-stocks-slide-novavax-shot-145617752.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’s shots showed they were 90% effective at preventing symptoms.\nStocks tied to inoculations already ...</p>\n\n<a href=\"https://finance.yahoo.com/news/vaccine-stocks-slide-novavax-shot-145617752.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE","MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/vaccine-stocks-slide-novavax-shot-145617752.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2143738859","content_text":"(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’s shots showed they were 90% effective at preventing symptoms.\nStocks tied to inoculations already cleared for emergency use fell in Monday’s trading, led by Moderna Inc.’s slide of as much as 9.5%. Pfizer Inc. fell 1.6% and the drugmaker’s German partner BioNTech SE dropped 6.1%. Even the consumer giant Johnson & Johnson slipped 0.6%, slightly more than the S&P 500 index as the broader market dropped back from Friday’s record highs.\nNovavax itself wasn’t immune from the downdraft it created, with the stock reversing a 9.5% gain on Monday to fall about 1%. The shot’s efficacy was better than Wall Street was expecting amid the spread of more resistant variants, and that’s raising the specter of new competition. Novavax now has “a viable alternative to mRNA vaccines,” like Pfizer and BioNTech or Moderna’s shots, an analyst at Jefferies said.\nBut with Novavax up 91% so far this year and after a more than 2,700% leap in 2020, it wasn’t enough to further bolster shares. Biotech stocks often climb ahead of highly watched catalyst, only to give back gains even after a positive update.","news_type":1},"isVote":1,"tweetType":1,"viewCount":219,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":150341784,"gmtCreate":1624888407948,"gmtModify":1703847113016,"author":{"id":"3581938241439452","authorId":"3581938241439452","authorIdStr":"3581938241439452","name":"melomo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581938241439452"},"themes":[],"htmlText":"lets get rich","listText":"lets get rich","text":"lets get rich","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/150341784","repostId":"2146835749","repostType":4,"repost":{"id":"2146835749","pubTimestamp":1624888031,"share":"https://ttm.financial/m/news/2146835749?lang=&edition=fundamental","pubTime":"2021-06-28 21:47","market":"us","language":"en","title":"3 Low-Risk Stocks for Conservative Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2146835749","media":"Motley Fool","summary":"These all-weather stocks can still help you build a market-beating portfolio.","content":"<p>The level of risk you're willing to maintain in your portfolio at any given time very much depends on your personal comfort level and investment goals. And the truth is, you don't need to hold a basket of high-risk/high-reward stocks to generate notable and consistent portfolio returns.</p>\n<p>If you want to maximize your portfolio growth without exposing yourself to excessive risk, there are plenty of high-quality stocks to pick from that can help you do just that. Let's take a look at three such safe stocks for long-term investors to buy right now.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4425f21b4312d33cf18d53a2231e7b89\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>When it comes to tried-and-true companies with a robust selection of products and a track record of resilience in a variety of economic conditions, <a href=\"https://laohu8.com/S/AONE\">one</a> of the top healthcare stocks that comes to mind is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). After nearly a century and a half in business, the company has pulled through many storms in its time, and the volatility of the pandemic market was no different.</p>\n<p>While Johnson &amp; Johnson reported mixed quarterly results in 2020, it still finished the full year with 0.6% total sales growth for the 12-month period. While that may seem like a modest increase, it's actually the same rate of sales growth the company reported in 2019 before the pandemic hit. Johnson &amp; Johnson's total sales growth in 2020 was bolstered by 3% sales growth in its consumer health segment and an 8% bump in pharmaceutical segment sales.</p>\n<p>In Johnson &amp; Johnson's most recent quarterly report for the first quarter of 2021, it was clear that the company's balance sheet was rebounding from any lag it may have experienced as a result of the pandemic. During the three-month period, the company's total sales increased 7.9% on a year-over-year basis, and its net earnings grew 7% year over year.</p>\n<p>In fact, Johnson &amp; Johnson's strong performance during the quarter led management to boost the company's full-year guidance. The company is targeting more than 9% adjusted operational sales growth and an increase in adjusted operational earnings per share (EPS) of approximately 17% for 2021.</p>\n<p>Johnson &amp; Johnson had several catalysts in its portfolio to thank for its robust top- and bottom-line growth in the first quarter, including single-digit sales increases in both its pharmaceutical and medical device segments. While overall sales in Johnson &amp; Johnson's consumer health segment fell slightly in the quarter, sales of its skin health/beauty, oral care, and baby care products still surged by respective rates of 4%, 6%, and 8% year over year.</p>\n<p>The company also recorded notable sales growth for a number of its top-selling pharmaceutical products. For example, first-quarter sales of its immunology drugs Stelara and Tremfya increased by respective amounts of 18% and 41% from the year-ago period. And sales of its oncology drugs Darzalex, Erleada, and Imbruvica popped 46%, 83%, and 9% year over year.</p>\n<p>Meanwhile, shares of Johnson &amp; Johnson have grown by more than 17% over the past year and about 5% year to date. Johnson &amp; Johnson is also a Dividend King that yields about 2.6% right now. And with nearly six decades of consecutive dividend boosts behind it, shareholders can be confident in the company's commitment to its payout. Long-term investors searching for an all-weather stock to buy can find safe harbor in Johnson &amp; Johnson's stable growth trajectory, steady share price increases, and robust dividend.</p>\n<h2>2. Costco Wholesale</h2>\n<p>If you're searching for another stable stock to add to your buy basket, <b>Costco Wholesale</b> (NASDAQ:COST) is a smart choice to add to your list. The company owns and operates hundreds of warehouses around the world, with its most robust presence in North America. Costco also has a burgeoning e-commerce presence that has gone from strength to strength since the beginning of the pandemic.</p>\n<p>Costco reports its fiscal year a bit differently than some other companies. Its fiscal 2020 concluded on Aug. 30, 2020. During the 12-month period, the company's net sales grew by more than 9%, while its comparable sales increased by about 8%. However, e-commerce comparable sales jumped by an eye-popping 50% compared to fiscal 2019.</p>\n<p>In the first three quarters of Costco's fiscal 2021 (ended Nov. 22, Feb. 14, and May 9), it reported net sales increases of 17%, 15%, and 22% from the year-ago periods. The company's comparable sales for these quarters also marked double-digit increases of 15%, 13%, and 21% on a year-over-year basis.</p>\n<p>Once again, Costco recorded the largest rates of year-over-year growth from e-commerce sales. During the first three quarters of the company's fiscal 2021, its e-commerce comp sales spiked by respective percentages of 86%, 76%, and 41% from the same quarters in fiscal 2020.</p>\n<p>Costco owes its stellar financial performance in varied market conditions to the constant demand for its products and services, which also makes it an appealing buy for long-term investors. The company was <a href=\"https://laohu8.com/S/AONE.U\">one</a> of a number of big-box retailers that maintained \"essential business\" status during the lockdown days of the pandemic. From daily essentials, to clothing, to electronics, to household appliances, to pharmacy services, members can find just about anything they need at Costco's warehouses.</p>\n<p>As Costco's business and balance sheet have continued to expand during the pandemic, so has its share price. The stock is currently trading more than 30% higher than one year ago and is up 4% from the beginning of this year.</p>\n<p>On a final note, Costco also pays a dividend that yields just a little under 1% at the time of this writing, and which it regularly increases. If you're looking for dividend income, consistent portfolio growth, and recession resilience, this high-caliber consumer staples stock offers investors the best of all worlds.</p>\n<h2>3. Procter &amp; Gamble</h2>\n<p>The final pick on today's list is another premium buy in the world of consumer staples. <b>Procter &amp; Gamble </b>(NYSE:PG) has been in business for nearly two centuries, and its comprehensive portfolio of products continues to drive meaningful growth regardless of market headwinds or periods of economic downturn.</p>\n<p>The company pays a healthy dividend that yields about 2.6% based on current share prices. Like Johnson &amp; Johnson, Procter &amp; Gamble is a Dividend King, but with an even lengthier track record of dividend increases. The company has consistently increased its dividend payout for 64 years in a row.</p>\n<p>Procter &amp; Gamble's products are used daily in households around the world, and it has a brand authority few companies can compete with. Among its family of brands are well-known names like Vicks, Pepto-Bismol, Ivory, Olay, Old Spice, Febreze, Gillette, Bounty, Charmin, and Tide. The durable demand for Procter &amp; Gamble's products and its established history of growth makes the company an appealing stock buy in any market environment.</p>\n<p>In the first three quarters of the company's fiscal 2021 (ended Sep. 30, Dec. 31, and March 31), Procter &amp; Gamble said that its net sales grew by respective rates of 9%, 8%, and 5% from the year-ago periods. The company also consistently increased its net earnings on a year-over-year basis during these three quarters: 19% in the first, 4% in the second, and 12% in the third.</p>\n<p>The company closed the most recent quarter with $10 billion in cash and cash equivalents out of about $117 billion in total assets. It also reported that it had approximately $8.8 billion in debt due within the next year, giving it plenty of liquidity to pay down its liabilities and continue covering its shareholder obligations. And Procter &amp; Gamble generated $4.1 billion in operating cash flow in the third quarter of its fiscal 2021 alone.</p>\n<p>Shares of Procter &amp; Gamble have retracted slightly from the beginning of the year but are still trading about 17% higher than this time last year.</p>\n<p>With its juicy dividend yield and strong balance sheet performance both through the decades and amid the tumultuous market conditions of the past year plus, Procter &amp; Gamble is a golden egg to add to your portfolio that can generate consistent growth for the long haul.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Low-Risk Stocks for Conservative Investors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Low-Risk Stocks for Conservative Investors\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-28 21:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/28/3-low-risk-stocks-for-conservative-investors/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The level of risk you're willing to maintain in your portfolio at any given time very much depends on your personal comfort level and investment goals. And the truth is, you don't need to hold a ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/28/3-low-risk-stocks-for-conservative-investors/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COST":"好市多","JNJ":"强生","PG":"宝洁","ISBC":"投资者银行"},"source_url":"https://www.fool.com/investing/2021/06/28/3-low-risk-stocks-for-conservative-investors/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146835749","content_text":"The level of risk you're willing to maintain in your portfolio at any given time very much depends on your personal comfort level and investment goals. And the truth is, you don't need to hold a basket of high-risk/high-reward stocks to generate notable and consistent portfolio returns.\nIf you want to maximize your portfolio growth without exposing yourself to excessive risk, there are plenty of high-quality stocks to pick from that can help you do just that. Let's take a look at three such safe stocks for long-term investors to buy right now.\nImage source: Getty Images.\n1. Johnson & Johnson\nWhen it comes to tried-and-true companies with a robust selection of products and a track record of resilience in a variety of economic conditions, one of the top healthcare stocks that comes to mind is Johnson & Johnson (NYSE:JNJ). After nearly a century and a half in business, the company has pulled through many storms in its time, and the volatility of the pandemic market was no different.\nWhile Johnson & Johnson reported mixed quarterly results in 2020, it still finished the full year with 0.6% total sales growth for the 12-month period. While that may seem like a modest increase, it's actually the same rate of sales growth the company reported in 2019 before the pandemic hit. Johnson & Johnson's total sales growth in 2020 was bolstered by 3% sales growth in its consumer health segment and an 8% bump in pharmaceutical segment sales.\nIn Johnson & Johnson's most recent quarterly report for the first quarter of 2021, it was clear that the company's balance sheet was rebounding from any lag it may have experienced as a result of the pandemic. During the three-month period, the company's total sales increased 7.9% on a year-over-year basis, and its net earnings grew 7% year over year.\nIn fact, Johnson & Johnson's strong performance during the quarter led management to boost the company's full-year guidance. The company is targeting more than 9% adjusted operational sales growth and an increase in adjusted operational earnings per share (EPS) of approximately 17% for 2021.\nJohnson & Johnson had several catalysts in its portfolio to thank for its robust top- and bottom-line growth in the first quarter, including single-digit sales increases in both its pharmaceutical and medical device segments. While overall sales in Johnson & Johnson's consumer health segment fell slightly in the quarter, sales of its skin health/beauty, oral care, and baby care products still surged by respective rates of 4%, 6%, and 8% year over year.\nThe company also recorded notable sales growth for a number of its top-selling pharmaceutical products. For example, first-quarter sales of its immunology drugs Stelara and Tremfya increased by respective amounts of 18% and 41% from the year-ago period. And sales of its oncology drugs Darzalex, Erleada, and Imbruvica popped 46%, 83%, and 9% year over year.\nMeanwhile, shares of Johnson & Johnson have grown by more than 17% over the past year and about 5% year to date. Johnson & Johnson is also a Dividend King that yields about 2.6% right now. And with nearly six decades of consecutive dividend boosts behind it, shareholders can be confident in the company's commitment to its payout. Long-term investors searching for an all-weather stock to buy can find safe harbor in Johnson & Johnson's stable growth trajectory, steady share price increases, and robust dividend.\n2. Costco Wholesale\nIf you're searching for another stable stock to add to your buy basket, Costco Wholesale (NASDAQ:COST) is a smart choice to add to your list. The company owns and operates hundreds of warehouses around the world, with its most robust presence in North America. Costco also has a burgeoning e-commerce presence that has gone from strength to strength since the beginning of the pandemic.\nCostco reports its fiscal year a bit differently than some other companies. Its fiscal 2020 concluded on Aug. 30, 2020. During the 12-month period, the company's net sales grew by more than 9%, while its comparable sales increased by about 8%. However, e-commerce comparable sales jumped by an eye-popping 50% compared to fiscal 2019.\nIn the first three quarters of Costco's fiscal 2021 (ended Nov. 22, Feb. 14, and May 9), it reported net sales increases of 17%, 15%, and 22% from the year-ago periods. The company's comparable sales for these quarters also marked double-digit increases of 15%, 13%, and 21% on a year-over-year basis.\nOnce again, Costco recorded the largest rates of year-over-year growth from e-commerce sales. During the first three quarters of the company's fiscal 2021, its e-commerce comp sales spiked by respective percentages of 86%, 76%, and 41% from the same quarters in fiscal 2020.\nCostco owes its stellar financial performance in varied market conditions to the constant demand for its products and services, which also makes it an appealing buy for long-term investors. The company was one of a number of big-box retailers that maintained \"essential business\" status during the lockdown days of the pandemic. From daily essentials, to clothing, to electronics, to household appliances, to pharmacy services, members can find just about anything they need at Costco's warehouses.\nAs Costco's business and balance sheet have continued to expand during the pandemic, so has its share price. The stock is currently trading more than 30% higher than one year ago and is up 4% from the beginning of this year.\nOn a final note, Costco also pays a dividend that yields just a little under 1% at the time of this writing, and which it regularly increases. If you're looking for dividend income, consistent portfolio growth, and recession resilience, this high-caliber consumer staples stock offers investors the best of all worlds.\n3. Procter & Gamble\nThe final pick on today's list is another premium buy in the world of consumer staples. Procter & Gamble (NYSE:PG) has been in business for nearly two centuries, and its comprehensive portfolio of products continues to drive meaningful growth regardless of market headwinds or periods of economic downturn.\nThe company pays a healthy dividend that yields about 2.6% based on current share prices. Like Johnson & Johnson, Procter & Gamble is a Dividend King, but with an even lengthier track record of dividend increases. The company has consistently increased its dividend payout for 64 years in a row.\nProcter & Gamble's products are used daily in households around the world, and it has a brand authority few companies can compete with. Among its family of brands are well-known names like Vicks, Pepto-Bismol, Ivory, Olay, Old Spice, Febreze, Gillette, Bounty, Charmin, and Tide. The durable demand for Procter & Gamble's products and its established history of growth makes the company an appealing stock buy in any market environment.\nIn the first three quarters of the company's fiscal 2021 (ended Sep. 30, Dec. 31, and March 31), Procter & Gamble said that its net sales grew by respective rates of 9%, 8%, and 5% from the year-ago periods. The company also consistently increased its net earnings on a year-over-year basis during these three quarters: 19% in the first, 4% in the second, and 12% in the third.\nThe company closed the most recent quarter with $10 billion in cash and cash equivalents out of about $117 billion in total assets. It also reported that it had approximately $8.8 billion in debt due within the next year, giving it plenty of liquidity to pay down its liabilities and continue covering its shareholder obligations. And Procter & Gamble generated $4.1 billion in operating cash flow in the third quarter of its fiscal 2021 alone.\nShares of Procter & Gamble have retracted slightly from the beginning of the year but are still trading about 17% higher than this time last year.\nWith its juicy dividend yield and strong balance sheet performance both through the decades and amid the tumultuous market conditions of the past year plus, Procter & Gamble is a golden egg to add to your portfolio that can generate consistent growth for the long haul.","news_type":1},"isVote":1,"tweetType":1,"viewCount":73,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184893029,"gmtCreate":1623697122361,"gmtModify":1704208941714,"author":{"id":"3581938241439452","authorId":"3581938241439452","authorIdStr":"3581938241439452","name":"melomo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581938241439452"},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/184893029","repostId":"2143787080","repostType":4,"repost":{"id":"2143787080","pubTimestamp":1623678240,"share":"https://ttm.financial/m/news/2143787080?lang=&edition=fundamental","pubTime":"2021-06-14 21:44","market":"us","language":"en","title":"DoorDash Announces Partnership with PetSmart® Offering On-Demand Delivery of Pet Essentials","url":"https://stock-news.laohu8.com/highlight/detail?id=2143787080","media":"PR Newswire","summary":"Customers nationwide can now access same-day delivery of pet supplies through DoorDash\nSAN FRANCISCO","content":"<div>\n<p>Customers nationwide can now access same-day delivery of pet supplies through DoorDash\nSAN FRANCISCO, June 14, 2021 /PRNewswire/ -- DoorDash (NYSE: DASH), the nation's leading last-mile logistics ...</p>\n\n<a href=\"https://finance.yahoo.com/news/doordash-announces-partnership-petsmart-offering-130000428.html\">Web Link</a>\n\n</div>\n","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DoorDash Announces Partnership with PetSmart® Offering On-Demand Delivery of Pet Essentials</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDoorDash Announces Partnership with PetSmart® Offering On-Demand Delivery of Pet Essentials\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 21:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/doordash-announces-partnership-petsmart-offering-130000428.html><strong>PR Newswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Customers nationwide can now access same-day delivery of pet supplies through DoorDash\nSAN FRANCISCO, June 14, 2021 /PRNewswire/ -- DoorDash (NYSE: DASH), the nation's leading last-mile logistics ...</p>\n\n<a href=\"https://finance.yahoo.com/news/doordash-announces-partnership-petsmart-offering-130000428.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DASH":"DoorDash, Inc."},"source_url":"https://finance.yahoo.com/news/doordash-announces-partnership-petsmart-offering-130000428.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2143787080","content_text":"Customers nationwide can now access same-day delivery of pet supplies through DoorDash\nSAN FRANCISCO, June 14, 2021 /PRNewswire/ -- DoorDash (NYSE: DASH), the nation's leading last-mile logistics platform, announced today a partnership with leading pet specialty retailer PetSmart to facilitate on-demand delivery of pet supplies and accessories across nearly 1,500 PetSmart locations nationwide. Customers can now order pet products for on-demand delivery through the DoorDash app or website in addition to the Petsmart.com website for same-day delivery powered exclusively through DoorDash Drive, DoorDash's white-label fulfillment platform that powers direct delivery for any business.\n\nDoorDash will offer more than 11,000 items from PetSmart including pet food, toys and treats, habitats and supplements, and more. Pet parents can now shop for everything they need for the lifetime care of their pets in a convenient and accessible way through the DoorDash app.\n\"As we continue to accelerate our entry into new categories to meet consumers' adapting on-demand needs, we are thrilled by the opportunity to continue to work with PetSmart to provide pet owners with all the animal essentials they need conveniently and reliably right on the DoorDash app,\" said Christopher Payne, President at DoorDash.\n\"At PetSmart we understand our customers' needs are always evolving,\" said Will Smith, Senior Vice President and Chief Marketing Officer at PetSmart. \"We're delighted to partner with DoorDash to provide pet parents with access to the essentials they need, right when they need them.\"\nDoorDash partner and NASCAR driver Bubba Wallace and his dog Asher star in the new DoorDash multi-platform marketing campaign to celebrate the launch of the partnership with PetSmart. \"Asher the Dasher\"–a high-energy TV, digital, social, campaign–will launch with a :30 TV spot  featuring Bubba Wallace and Asher airing today with additional video content running across social and digital.\n\"As a new pet parent, I am so excited to see DoorDash partner with PetSmart to make same-day delivery of pet supplies a reality,\" said Bubba Wallace. \"Whether Asher is with me on the road or at home, the fact that I can now order him all his favorite treats and essentials and get them delivered on-demand is a gamechanger.\"\nPetSmart is available on DashPass, DoorDash's membership program that offers members unlimited $0 delivery fees and reduced service fees from thousands of restaurants, grocery, and convenience stores nationwide. DashPass members can enjoy these benefits on all eligible orders from PetSmart.\n\"Asher the Dasher\" was created in partnership with Bokeh, a SF-based creative agency tasked with bringing the campaign to life. The campaign was directed by Paul Trillo and produced by Greg Speck with Monica Lo as Creative Director.\nAbout DoorDash\nDoorDash is a technology company that connects consumers with their favorite local and national businesses in more than 4,000 cities and all 50 states across the United States, Canada, and Australia. Founded in 2013, DoorDash enables local businesses to address consumers' expectations of ease and immediacy and thrive in today's convenience economy. By building the last-mile logistics infrastructure for local commerce, DoorDash is bringing communities closer, one doorstep at a time.\nAbout PetSmart\nPetSmart LLC is the largest specialty pet retailer of services and solutions for the lifetime needs of pets. At PetSmart, we love pets, and we believe pets make us better people. Every day with every connection, PetSmart's passionate associates help bring pet parents closer to their pets so they, together, can live more fulfilled lives. This vision impacts everything we do for our customers, the way we support our associates and how we give back to our communities.\nPetSmart operates approximately 1,650 pet stores in the United States, Canada and Puerto Rico, as well as more than 200 in-store PetSmart PetsHotel® dog and cat boarding facilities. The retailer provides a broad range of competitively priced pet food and products, as well as services such as dog training, pet grooming, pet boarding, PetSmart Doggie Day Camp™ and pet adoption.\nPetSmart, PetSmart Charities® and PetSmart Charities® of Canada work with nearly 4,000 animal welfare organizations to bring adoptable pets into stores so they have the best chance possible of finding a forever home. Through this in-store adoption program and other signature events, PetSmart has facilitated more than 9 million adoptions, more than any other brick-and-mortar organization.","news_type":1},"isVote":1,"tweetType":1,"viewCount":482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184899289,"gmtCreate":1623697094241,"gmtModify":1704208941230,"author":{"id":"3581938241439452","authorId":"3581938241439452","authorIdStr":"3581938241439452","name":"melomo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581938241439452"},"themes":[],"htmlText":"hao","listText":"hao","text":"hao","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184899289","repostId":"2143738859","repostType":4,"repost":{"id":"2143738859","pubTimestamp":1623684317,"share":"https://ttm.financial/m/news/2143738859?lang=&edition=fundamental","pubTime":"2021-06-14 23:25","market":"us","language":"en","title":"Vaccine Stocks Slide After Novavax Shot Proves Highly Effective","url":"https://stock-news.laohu8.com/highlight/detail?id=2143738859","media":"Bloomberg","summary":"(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’","content":"<p>(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’s shots showed they were 90% effective at preventing symptoms.</p>\n<p>Stocks tied to inoculations already cleared for emergency use fell in Monday’s trading, led by Moderna Inc.’s slide of as much as 9.5%. Pfizer Inc. fell 1.6% and the drugmaker’s German partner <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> dropped 6.1%. Even the consumer giant Johnson &amp; Johnson slipped 0.6%, slightly more than the S&amp;P 500 index as the broader market dropped back from Friday’s record highs.</p>\n<p>Novavax itself wasn’t immune from the downdraft it created, with the stock reversing a 9.5% gain on Monday to fall about 1%. The shot’s efficacy was better than Wall Street was expecting amid the spread of more resistant variants, and that’s raising the specter of new competition. Novavax now has “a viable alternative to mRNA vaccines,” like Pfizer and BioNTech or Moderna’s shots, an analyst at Jefferies said.</p>\n<p>But with Novavax up 91% so far this year and after a more than 2,700% leap in 2020, it wasn’t enough to further bolster shares. Biotech stocks often climb ahead of highly watched catalyst, only to give back gains even after a positive update.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks Slide After Novavax Shot Proves Highly Effective</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks Slide After Novavax Shot Proves Highly Effective\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 23:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/vaccine-stocks-slide-novavax-shot-145617752.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’s shots showed they were 90% effective at preventing symptoms.\nStocks tied to inoculations already ...</p>\n\n<a href=\"https://finance.yahoo.com/news/vaccine-stocks-slide-novavax-shot-145617752.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE","MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/vaccine-stocks-slide-novavax-shot-145617752.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2143738859","content_text":"(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’s shots showed they were 90% effective at preventing symptoms.\nStocks tied to inoculations already cleared for emergency use fell in Monday’s trading, led by Moderna Inc.’s slide of as much as 9.5%. Pfizer Inc. fell 1.6% and the drugmaker’s German partner BioNTech SE dropped 6.1%. Even the consumer giant Johnson & Johnson slipped 0.6%, slightly more than the S&P 500 index as the broader market dropped back from Friday’s record highs.\nNovavax itself wasn’t immune from the downdraft it created, with the stock reversing a 9.5% gain on Monday to fall about 1%. The shot’s efficacy was better than Wall Street was expecting amid the spread of more resistant variants, and that’s raising the specter of new competition. Novavax now has “a viable alternative to mRNA vaccines,” like Pfizer and BioNTech or Moderna’s shots, an analyst at Jefferies said.\nBut with Novavax up 91% so far this year and after a more than 2,700% leap in 2020, it wasn’t enough to further bolster shares. Biotech stocks often climb ahead of highly watched catalyst, only to give back gains even after a positive update.","news_type":1},"isVote":1,"tweetType":1,"viewCount":219,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184891173,"gmtCreate":1623697244792,"gmtModify":1704208943656,"author":{"id":"3581938241439452","authorId":"3581938241439452","authorIdStr":"3581938241439452","name":"melomo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581938241439452"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184891173","repostId":"1135770375","repostType":4,"repost":{"id":"1135770375","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623678372,"share":"https://ttm.financial/m/news/1135770375?lang=&edition=fundamental","pubTime":"2021-06-14 21:46","market":"us","language":"en","title":"Lordstown shares tumbled nearly 20% in moring trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1135770375","media":"Tiger Newspress","summary":"Lordstown shares tumbled nearly 20% in moring trading.\n\nElectric-vehicle maker Lordstown Motors Corp","content":"<p>Lordstown&nbsp;shares&nbsp;tumbled&nbsp;nearly&nbsp;20%&nbsp;in&nbsp;moring&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/71ab214ec35da9043a3ec41746785e3f\" tg-width=\"800\" tg-height=\"625\" referrerpolicy=\"no-referrer\"></p>\n<p>Electric-vehicle maker <a href=\"https://laohu8.com/S/RIDE\">Lordstown Motors Corp.</a> announced the abrupt departure of its two top executives as it attempts to transition from research and development into commercial production of its first model.</p>\n<p>The startup said in a statement Monday that Chief Executive Officer Steve Burns and Chief Financial Officer Julio Rodriguez have resigned from the company, effective immediately.</p>\n<p>It is the latest setback for the company, which warned last week it might not have enough cash to fund development of its first truck or even survive the next 12 months if it can’t raise more capital. In March, the startup disclosed a Securities and Exchange Commission probe of its operations after a short seller said its technology was flawed and that pre-orders for its truck were nonbinding.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lordstown shares tumbled nearly 20% in moring trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLordstown shares tumbled nearly 20% in moring trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-14 21:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Lordstown&nbsp;shares&nbsp;tumbled&nbsp;nearly&nbsp;20%&nbsp;in&nbsp;moring&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/71ab214ec35da9043a3ec41746785e3f\" tg-width=\"800\" tg-height=\"625\" referrerpolicy=\"no-referrer\"></p>\n<p>Electric-vehicle maker <a href=\"https://laohu8.com/S/RIDE\">Lordstown Motors Corp.</a> announced the abrupt departure of its two top executives as it attempts to transition from research and development into commercial production of its first model.</p>\n<p>The startup said in a statement Monday that Chief Executive Officer Steve Burns and Chief Financial Officer Julio Rodriguez have resigned from the company, effective immediately.</p>\n<p>It is the latest setback for the company, which warned last week it might not have enough cash to fund development of its first truck or even survive the next 12 months if it can’t raise more capital. In March, the startup disclosed a Securities and Exchange Commission probe of its operations after a short seller said its technology was flawed and that pre-orders for its truck were nonbinding.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135770375","content_text":"Lordstown shares tumbled nearly 20% in moring trading.\n\nElectric-vehicle maker Lordstown Motors Corp. announced the abrupt departure of its two top executives as it attempts to transition from research and development into commercial production of its first model.\nThe startup said in a statement Monday that Chief Executive Officer Steve Burns and Chief Financial Officer Julio Rodriguez have resigned from the company, effective immediately.\nIt is the latest setback for the company, which warned last week it might not have enough cash to fund development of its first truck or even survive the next 12 months if it can’t raise more capital. In March, the startup disclosed a Securities and Exchange Commission probe of its operations after a short seller said its technology was flawed and that pre-orders for its truck were nonbinding.","news_type":1},"isVote":1,"tweetType":1,"viewCount":240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184899746,"gmtCreate":1623697108385,"gmtModify":1704208941391,"author":{"id":"3581938241439452","authorId":"3581938241439452","authorIdStr":"3581938241439452","name":"melomo","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581938241439452"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184899746","repostId":"2143780690","repostType":4,"repost":{"id":"2143780690","pubTimestamp":1623680040,"share":"https://ttm.financial/m/news/2143780690?lang=&edition=fundamental","pubTime":"2021-06-14 22:14","market":"us","language":"en","title":"Lilly to Participate in Guggenheim Biopharma Strategy Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2143780690","media":"PR Newswire","summary":"INDIANAPOLIS, June 14, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in th","content":"<div>\n<p>INDIANAPOLIS, June 14, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Biopharma Strategy Series – Biopharma's Next Decade: Views from the Top on Global ...</p>\n\n<a href=\"https://finance.yahoo.com/news/lilly-participate-guggenheim-biopharma-strategy-140000747.html\">Web Link</a>\n\n</div>\n","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lilly to Participate in Guggenheim Biopharma Strategy Series</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLilly to Participate in Guggenheim Biopharma Strategy Series\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 22:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/lilly-participate-guggenheim-biopharma-strategy-140000747.html><strong>PR Newswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>INDIANAPOLIS, June 14, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Biopharma Strategy Series – Biopharma's Next Decade: Views from the Top on Global ...</p>\n\n<a href=\"https://finance.yahoo.com/news/lilly-participate-guggenheim-biopharma-strategy-140000747.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://finance.yahoo.com/news/lilly-participate-guggenheim-biopharma-strategy-140000747.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2143780690","content_text":"INDIANAPOLIS, June 14, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Biopharma Strategy Series – Biopharma's Next Decade: Views from the Top on Global Strategy and Innovation – on Friday, June 18, 2021. Daniel Skovronsky, M.D., Ph.D., Lilly's Chief Scientific and Medical Officer and President of Lilly Research Laboratories, will participate in a virtual fireside chat at 11:00 a.m., Eastern Time.\nA live audio webcast will be available on the \"Webcasts & Presentations\" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.\nAbout Eli Lilly and Company \nLilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/news. F-LLY","news_type":1},"isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}